10-18-2017
SPPI news:
Oral presentation of data from a Phase 2 clinical study evaluating Poziotinib for the treatment of lung cancer while presenting at the 18th IASLC World Conference in Japan.
Yahoo discussion - https://finance.yahoo.com/quote/SPPI/community?p=SPPI
